BCA
ETON icon

Berman Capital Advisors’s Eton Pharmaceutcials ETON Stock Holding History

Berman Capital Advisors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-229
Closed -$1K – 2111
2021
Q2 		$1K Hold
229
– – ﹤0.01% 1731
2021
Q1 		$1K Hold
229
– – ﹤0.01% 1628
2020
Q4 		$1K Buy
229
+36
+19% +$278 ﹤0.01% 1523
2020
Q3 		$1K Hold
193
– – ﹤0.01% 1442
2020
Q2 		$1K Buy
+193
New +$958 ﹤0.01% 1411

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berman Capital Advisors's ETON Position: Q3 2021 in Review

Berman Capital Advisors sold out of Eton Pharmaceutcials (ETON) in Q3 2021, closing a stake of 229 shares — an estimated $1K sold.

Berman Capital Advisors first reported a position in ETON in Q2 2020 and held it in 5 quarters. The position peaked at $1K in Q2 2021. 37 funds tracked by Wall St. Rank hold ETON as of Q3 2021.

  • Berman Capital Advisors reported no remaining Eton Pharmaceutcials position as of Q3 2021 after selling out during the quarter.
  • Berman Capital Advisors sold 229 Eton Pharmaceutcials shares in Q3 2021, an estimated $1K.
  • Berman Capital Advisors first reported a position in Eton Pharmaceutcials in Q2 2020 and held it in 5 quarters.
  • Berman Capital Advisors's Eton Pharmaceutcials position peaked at $1K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.